Growth Metrics

Palisade Bio (PALI) Share-based Compensation Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 206.26%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -69.95%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.18%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.66%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 23.70%
10 Palisade Bio 439.25 Mn 309.68 Mn - 7,428.07%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 7,428.07%
Dec 31, 2025 945.91%
Sep 30, 2025 -7.61%
Jun 30, 2025 -52.00%
Mar 31, 2025 0.00%
Dec 31, 2024 -172.61%
Sep 30, 2024 -52.08%
Jun 30, 2024 -13.19%
Mar 31, 2024 -38.71%
Dec 31, 2023 604.65%
Sep 30, 2023 -23.81%
Jun 30, 2023 -57.14%
Mar 31, 2023 -74.02%
Dec 31, 2022 -87.41%
Sep 30, 2022 144.66%
Jun 30, 2022 -32.12%
Mar 31, 2022 -37.08%
Dec 31, 2021 45.32%
Sep 30, 2021 -84.49%
Jun 30, 2021 25.95%
Mar 31, 2021 649.75%
Dec 31, 2020 293.49%
Sep 30, 2020 125.39%
Jun 30, 2020 205.18%
Mar 31, 2020 -77.54%
Dec 31, 2019 87.19%
Sep 30, 2019 118.72%
Jun 30, 2019 -34.54%
Mar 31, 2019 41.51%
Dec 31, 2018 -76.00%
Sep 30, 2018 -59.15%
Jun 30, 2018 -69.82%
Mar 31, 2018 -54.28%
Dec 31, 2017 -54.07%
Sep 30, 2017 -43.03%
Jun 30, 2017 -20.21%
Mar 31, 2017 -64.48%
Dec 31, 2016 -30.30%
Sep 30, 2016 -28.12%
Jun 30, 2016 30.53%
Mar 31, 2016 113.22%
Dec 31, 2015 21.91%
Sep 30, 2015 22.57%
Jun 30, 2015 15.70%
Mar 31, 2015 -71.74%
Dec 31, 2014 171.72%
Sep 30, 2014 -34.79%
Jun 30, 2014 -9.31%
Mar 31, 2014 412.05%
Dec 31, 2013 -40.76%
Sep 30, 2013 107.00%
Jun 30, 2013 80.39%
Mar 31, 2013 28.74%
Dec 31, 2012 -7.69%
Sep 30, 2012 -27.10%
Jun 30, 2012 -68.75%
Mar 31, 2012 -67.76%
Dec 31, 2011 -64.69%
Sep 30, 2011 -49.11%